Adrian N. Hobden

Adrian N. Hobden has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Myriad Genetics Inc and Myriad Pharmaceuticals, Inc. Between 27 April 2006 and 24 September 2010, the trades on record add up to 36 filings.

In open-market terms, that means 1 purchase worth €65k on one side and 11 sales worth €6.7M on the other. Taken together, the sales exceed the purchases by €6.6M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants and 22 option exercises. 2010 to date brings 1 purchase and no sales.

On 28 September 2010 came the latest disclosure, a share grant in Myriad Pharmaceuticals, Inc. The last insider purchase was made public on 19 March 2010, 6,079 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.